(vii) maintenance of books and records; (viii) rights of inspection; (ix) compliance with laws and regulations; (x) use of proceeds; (xi) additional subsidiary guarantors and other further assurances; and (xii) fulfillment of certain post-closing obligations.
The Credit Agreement provides for customary events of default includingnon-payment of obligations, inaccuracy of representations or warranty,non-performance of covenants and obligations, default on other material debt, bankruptcy or insolvency events, material judgments, change of control, material ERISA events and certain customary events of default relating to collateral or guarantees. Upon the occurrence of any event of default, subject to the terms of the Credit Agreement including any cure periods specified therein, customary remedies may be exercised by the lenders under the Credit Agreement against us and our properties.
The foregoing summary of the Credit Agreement does not purport to be complete and is subject to, and qualified in its entirety by reference to, the Credit Agreement, which is filed as Exhibit A to Exhibit 10.21 to the registration statement of which this prospectus forms a part.
Stock Purchase Agreement, Registration Rights Agreement and Nomination Agreement
In connection with the execution of the Credit Agreement, on May 9, 2020, we entered into the Purchase Agreement with FP. Pursuant to the terms of the Purchase Agreement, FP agreed to purchase 2,599,174 shares of our Class A common stock from us at a price of $0.01 per share, for a total purchase price of $25,991.74, upon the funding of the Initial Term Loans pursuant to the Credit Agreement. On May 19, 2020, having completed the funding of the Initial Term Loans, FP purchased the 2,599,174 shares of Class A common stock pursuant to the Purchase Agreement, and we simultaneously entered into the Registration Rights Agreement with FP as part of the closing of the sale of the shares to FP. Pursuant to the terms of the Registration Rights Agreement, we have filed with the SEC the registration statement that includes this prospectus to register for resale under the Securities Act of 1933, as amended, or Securities Act, the shares that were issued to FP under the Purchase Agreement. See “Description of Capital Stock–FP Registration Rights” for additional information about the Registration Rights Agreement.
On May 19, 2020, we also entered into a Nomination Agreement, or Nomination Agreement, with FP and Francisco Partners Management, L.P., or FP Parent, pursuant to which, among other things, for so long as a principal amount of at least $62.5 million remains outstanding under the Credit Agreement, or Nomination Threshold, FP shall have the right to designate a nominee for election to our Board of Directors, or Board, as a Class III Director, or FP Designee, at each meeting of our stockholders at which the Class III Directors are to stand for election, subject to certain provisions as described in the Nomination Agreement, including that the FP Designee be independent of FP Parent and otherwise be acceptable to us in our reasonable discretion. Pursuant to the Nomination Agreement, at any time that the Nomination Threshold is not satisfied, the FP Designee (including any successors designated pursuant to the Nomination Agreement) shall promptly offer to resign from the Board. In the event the Nomination Threshold is not satisfied, FP will not regain the right to designate a FP Designee. In addition, under the Nomination Agreement, for so long as the Nomination Threshold is satisfied, FP shall have the right to designate a Board observer. As of the date of this prospectus, FP has not designated the FP Designee.
Pursuant to the Nomination Agreement, until the later of May 19, 2022 and the date on which the Nomination Threshold is not satisfied, and subject to certain customary exceptions, FP Parent and its affiliates shall not (a) effect or seek, offer or propose to effect, or announce any intention to effect or cause or participate in or in any way assist, facilitate or encourage any other person to effect or seek, offer or propose to effect or participate in, (i) any acquisition of any of our or our subsidiaries’ equity securities, rights or options to acquire any of our or our subsidiaries’ equity securities, or any of our or our subsidiaries’ assets or businesses, (ii) any tender or exchange offer, merger or other business combination involving us or our subsidiaries or our or our subsidiaries’ assets constituting a significant portion of our and our subsidiaries’ consolidated assets, or (iii) any “solicitation” of “proxies” (as such terms are used in the proxy rules of the SEC) or consents to vote any of our or
8